Sabizabulin

Veru Inc. (NASDAQ: VERU) shares could gap-open lower on Thursday following a negative Food and Drug Administration Panel verdict for its COVID-19 treatment candidate. What Happened: Miami, Florida-based Veru announced late on Wednesday that FDA’s Pulmonary-Allergy Drugs Advisory Committee...

Veru Inc (NASDAQ: VERU) shot up 235% at one point on Monday before closing the trading session up more than 180% off Friday’s closing price. On Tuesday, the stock was consolidating the move higher by setting up an inside bar pattern on the daily chart. On Monday, Veru announced the...